156 related articles for article (PubMed ID: 22073815)
1. The fair transaction model of informed consent: an alternative to autonomous authorization.
Miller FG; Wertheimer A
Kennedy Inst Ethics J; 2011 Sep; 21(3):201-18. PubMed ID: 22073815
[TBL] [Abstract][Full Text] [Related]
2. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 7: Informed consent and xenotransplantation clinical trials.
Vanderpool HY
Xenotransplantation; 2009; 16(4):255-62. PubMed ID: 19799766
[TBL] [Abstract][Full Text] [Related]
3. Time to stop worrying about the therapeutic misconception.
Wendler DS
J Clin Ethics; 2012; 23(3):272-87. PubMed ID: 23256408
[TBL] [Abstract][Full Text] [Related]
4. Clinical research before informed consent.
Miller FG
Kennedy Inst Ethics J; 2014 Jun; 24(2):141-57. PubMed ID: 25109093
[TBL] [Abstract][Full Text] [Related]
5. The therapeutic misconception at 25: treatment, research, and confusion.
Kimmelman J
Hastings Cent Rep; 2007; 37(6):36-42. PubMed ID: 18179103
[TBL] [Abstract][Full Text] [Related]
6. Respecting autonomy without disclosing information.
Walker T
Bioethics; 2013 Sep; 27(7):388-94. PubMed ID: 22486227
[TBL] [Abstract][Full Text] [Related]
7. Problems with the consensus definition of the therapeutic misconception.
Wendler DS
J Clin Ethics; 2013; 24(4):387-94. PubMed ID: 24597427
[TBL] [Abstract][Full Text] [Related]
8. Improving subject recruitment by maintaining truly informed consent: a practical benefit of disclosing adverse clinical trial results.
Shah KR; Batzer FR
Am J Bioeth; 2009 Aug; 9(8):36-7. PubMed ID: 19998157
[No Abstract] [Full Text] [Related]
9. Why we should continue to worry about the therapeutic misconception.
Churchill LR; King NM; Henderson GE
J Clin Ethics; 2013; 24(4):381-6. PubMed ID: 24597426
[TBL] [Abstract][Full Text] [Related]
10. Respecting participant autonomy and the disclosure of clinical trial results.
Oakley J
Am J Bioeth; 2009 Aug; 9(8):38. PubMed ID: 19998158
[No Abstract] [Full Text] [Related]
11. Beyond informed consent: the therapeutic misconception and trust.
de Melo-MartÃn I; Ho A
J Med Ethics; 2008 Mar; 34(3):202-5. PubMed ID: 18316464
[TBL] [Abstract][Full Text] [Related]
12. Unrealistic optimism and the ethics of phase I cancer research.
Crites J; Kodish E
J Med Ethics; 2013 Jun; 39(6):403-6. PubMed ID: 23118468
[TBL] [Abstract][Full Text] [Related]
13. The problem with optimism in clinical trials.
Jansen LA
IRB; 2006; 28(4):13-9. PubMed ID: 17036434
[No Abstract] [Full Text] [Related]
14. Twenty-five years of therapeutic misconception.
Appelbaum PS; Lidz CW
Hastings Cent Rep; 2008; 38(2):5-6; author reply 6-7. PubMed ID: 18457217
[No Abstract] [Full Text] [Related]
15. What it takes to defend deceptive placebo use.
Barnhill A
Kennedy Inst Ethics J; 2011 Sep; 21(3):219-50. PubMed ID: 22073816
[TBL] [Abstract][Full Text] [Related]
16. Costs to subjects for research participation and the informed consent process: regulatory and ethical considerations.
Iltis AS
IRB; 2004; 26(6):9-13. PubMed ID: 15658017
[No Abstract] [Full Text] [Related]
17. The ubiquity and utility of the therapeutic misconception.
Dresser R
Soc Philos Policy; 2002; 19(2):271-94. PubMed ID: 12678090
[No Abstract] [Full Text] [Related]
18. Informed consent on trial.
Cressey D
Nature; 2012 Jan; 482(7383):16. PubMed ID: 22297946
[No Abstract] [Full Text] [Related]
19. Twenty-five years of therapeutic misconception.
Miller FG
Hastings Cent Rep; 2008; 38(2):6; author reply 6-7. PubMed ID: 18457218
[No Abstract] [Full Text] [Related]
20. Unconscious emotional reasoning and the therapeutic misconception.
Charuvastra A; Marder SR
J Med Ethics; 2008 Mar; 34(3):193-7. PubMed ID: 18316462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
